Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. Also in November, it reported positive data on its standout IND, CYB003. 10 Psychedelic Companies To Watch In 2022.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

JULY 11, 2022

The budget trailer bill eliminated the cannabis cultivation tax beginning July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. View source.].

Cultivation 52

Cultivation Law Collective Retail 52

Cannabis Law Report

MARCH 3, 2022

On February 28, 2022, the Oregon Psilocybin Services (OPS), a new section within the Oregon Health Authority (OHA), released results from a community interest survey concerning Oregon’s still-developing psilocybin program. The survey opened on January 7, 2022, and closed on February 6, 2022, receiving 4,421 total responses.

Programs 52

Programs Access Data Legislation 52

Cannabis Law Report

JANUARY 21, 2022

Fri, January 21, 2022, . market is expected to reach $43 billion by 2025, according to New Frontier Data. ” The transaction is expected to close this quarter, subject to regulatory approvals and other customary closing conditions. ©2018 – 2022 Dama Financial. SOUTH SAN FRANCISCO, Calif. , Jan. territories.

Supply Chain 52

Supply Chain Compliance Compliance Banking 52

Cannabis Law Report

JANUARY 3, 2022

According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases. In comparison, about 450 patients were prescribed a total of less than 5 kg of cannabis for therapeutic purposes in 2018. Source: [link].

Media 52

Media Chronic Pain Patients Treatment 52

Cannabis Law Report

APRIL 14, 2022

Local governments may also impose zoning conditions on cannabis facilities, including but not limited to buffer zones, density conditions, hours of operation, odor control requirements, necessary operating permits, and storefront characteristics. Water resource depletion has been a concern at both outdoor and indoor grow operations.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

MARCH 8, 2022

DENVER) March 8, 2022 – Simplifya (“Simplifya” or “the Company”), the leading regulatory and operational compliance software platform serving the cannabis industry, announced the launch of its comprehensive suite of compliance solutions in New Mexico, expanding the company’s reach to 24 states. Simplifya Self Audit.

Compliance 98

Compliance Compliance Research and Development Business 98

Cannabis Law Report

MAY 10, 2022

11 May 2022. First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

JULY 20, 2022

NEW YORK , July 19, 2022 /PRNewswire/ — Data Bridge Market research has recently released expansive research titled “ Global Cannabis Seeds Market ” guarantees you will remain better informed than your competition. According to Data Bridge Market Research, Global Cannabis Seeds Market was valued at USD 1,445.05

Seed-To-Sale 52

Seed-To-Sale Research and Development Ruderalis Data 52

Cannabis Law Report

AUGUST 27, 2021

The Rules will be effective until at least August 19, 2022. The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. There are two types of fees: application fees and license fees.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Veriheal

AUGUST 9, 2023

In contrast, a more significant proportion, 76%, recognized addiction as a medical condition, demonstrating increased understanding and compassion towards those facing such challenges. Results showed that 58% of respondents were aware of naloxone, but only 35% reported that they would know where to access it in an emergency.

Education 98

Education Vaping Cannabis Consumption 98

Cannabis Law Report

APRIL 21, 2022

Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022. 2022) Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America.

Pets 52

Pets Research and Development Topical Consumption 52

Veriheal

DECEMBER 27, 2022

Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. The subjective nature of self-reported data can plague research. Psychedelics can also cause hallucinations, out-of-body experiences, and other changes in perception.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Cannabis Law Report

JUNE 8, 2022

Published: Jun 07, 2022. Experienced healthcare leaders bring decades of experience in global drug commercialization and patient access. SAN JOSE, Calif. , June 7, 2022 /PRNewswire/ — MAPS Public Benefit Corp (MAPS PBC) today announced the appointment of Jeff George and Dan Grossman , Ph.D., He holds a Ph.D.

Therapy 52

Therapy Treatment Access Patients 52

Illinois News Joint

FEBRUARY 7, 2023

The disparity and availability study begins 12 months of research that will measure accessibility, whether any discrimination exists, whether it impacts entry and participation, and suggest potential remedies for Illinois cannabis regulation. The finished results of the report will be given to the Illinois General Assembly and Governor.

Agriculture 79

Agriculture Cannabis Policy Dispensary 79

Cannabis Law Report

JANUARY 11, 2022

Company selects NEO to access wider investor base and enhanced liquidity. Today, Trees becomes the first company to make its public markets debut on the NEO Exchange in 2022, and joins NEO’s growing list of cannabis issuers. Trees is now available for trading on NEO under the symbol TREE. Connect with Trees: Website | LinkedIn.

Retail 52

Retail Advocacy History Media 52

Veriheal

FEBRUARY 10, 2022

cloudPWR and Accela’s cloud-based registry has been publicly accessible since Nov. For the year 2022, patients who are interested in registering for South Dakota’s medical cannabis industry can apply with ease via the new fully digital internet-based program. Data and storage options via the integrated Microsoft Azure platform.

Programs 52

Programs Chronic Pain Patients Conditions 52

Cannabis Law Report

MAY 29, 2022

Schedule I controlled substances are the most restricted in terms of research, supply, and access, [13] and possession is criminalized. Fast Track review is for drugs that treat serious conditions and fill an unmet medical need. Brian Schatz & Cory Booker to Acting Director Tabak and Commissioner Califf (May 11, 2022), [link]. [2]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” In Q1 2022, Canopy has expanded its portfolio of THC beverages with Tweed Iced Tea beverages (available in lemon and raspberry flavors, both with 5 mg THC) now shipping. Net revenue. Adjusted EBITDA 3.

Data 95

Data Vaping Supply Chain Business 95

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

JANUARY 5, 2022

Young and Joyce also question the federal government’s motives, stating, “To be clear, we do not negate the benefit of traditional therapies, but question why the federal government continues to bar access to innovative, proven—and in many cases—safer alternatives.” Young’s Trail of Cannabis Reform.

Legislation 52

Legislation Cannabis Therapy Access 52

Cannabis Law Report

MAY 12, 2022

10 May 2022. The market has learned to adjust to less-than-ideal conditions while maintaining hope for progress in Washington. Access to information will help make operators more valuable to capital providers and in turn attract more funding to those providers. Joseph Cioffi. Davis+Gilbert LLP. Lending and Capital Alternatives.

Environment 52

Environment Banking Cannabis Data 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

JANUARY 20, 2022

Agrify brings data, science, and technology to its customers for unparalleled control over cultivation and extraction. Q4 2021 Bookings $150 Million Greater Than Prior Guidance of $100 Million. BILLERICA, Mass.,

Extraction 52

Extraction Cultivation Hemp Data 52

Cannabis Law Report

AUGUST 6, 2022

Such conditions have prodded Canopy into refocusing its product mix on the premium sector, which typically commands higher prices and generates a more loyal consumer basis than value items. . million or 28 cents per share, according to financial data firm Refinitiv. as the company’s biggest challenges.

Supply Chain 52

Supply Chain Cannabis Vaping Business 52

Cannabis Law Report

JULY 24, 2022

The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 Accordingly, the adopted amendment is intended to facilitate access to cannabis medicinal products for thousands of patients as part of their treatment. percent annually to $9.8 billion by 2029.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

OCTOBER 20, 2021

CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to provide an update on recent sales and market share data in Canada, along with the achievement of a key milestone in the US expansion. 1 All market share data is sourced from Headset. Flower Launch – Accessing 60% of the Canadian Cannabis Market. 3.17%. . .

Vaping 52

Vaping Concentrates Events Oil 52

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. At the time of FY 2020 results publication, we estimated that EUR 250m revenues had been lost in FY 2020 due to the impact of COVID-19 lockdowns and travel restrictions and the objective was to recover these revenues by 2022.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

MAY 6, 2022

May 6, 2022. Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Michelle R.E. Donovan , Leslie C. For the first time, the U.S.

THC 52

THC CBD Media Food 52

Cannabis Law Report

FEBRUARY 28, 2022

The transaction is subject to customary closing conditions, including applicable regulatory approvals. first loyalty program, provides exclusive access to promotions, product drops and content. Forward-looking statements depend on assumptions, data or methods that may be incorrect or imprecise and may not be able to be realized.

Events 52

Events Retail Business Dispensary 52

Cannabis Law Report

FEBRUARY 2, 2022

A material change report is not expected to be filed by the Company 21 days before the issuance of the Top-up Warrants as the details of the Amendments were only agreed as of February 1, 2022. In the view of the Company, this was reasonable in the circumstances because the Term Loans were due to mature on January 31, 2022.

Events 52

Events Business Retail Conditions 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JUNE 11, 2021

Total upfront consideration was approximately $240 million, comprised of $45 million in cash and $195 million in Columbia Care stock, with the potential for additional performance-based milestones in 2022 and 2023. Provides home delivery access throughout the state with 10 vehicles.

Dispensary 66

Dispensary Cultivation Research and Development Retail 66

Cannabis Law Report

OCTOBER 27, 2021

The pipeline of expected new orders in all three businesses – Produce, Cannabis, and Commercial – remains strong and is expected to support momentum into the fourth quarter and 2022. Interested parties may access the webcast through the Investors section of the Company’s website at www.gibraltar1.com GIBRALTAR INDUSTRIES, INC.

Supply Chain 52

Supply Chain Business Environment Data 52

Cannabis Law Report

NOVEMBER 9, 2021

BRAMPTON, Ontario–(BUSINESS WIRE)–DATA Communications Management Corp. million of interest savings in 2022, and these new term loans will effectively extend the amortization period of the Crown Capital facility, which has a “bullet” maturity in May 2023. About DATA Communications Management Corp. Eastern time.

Data 52

Data Business Supply Chain Banking 52